Abstract
Background We hypothesized that medication adherence is affected by the number of pharmacies a patient frequents. Objective The objective was to estimate the strength of association between the number of pharmacies a patient frequents and adherence to statins. Methods Using administrative data from the Nova Scotia Seniors’ Pharmacare program, a retrospective cohort study was conducted among subjects aged 65 years and older first dispensed a statin between 1998 and 2008. The Usual Provider of Care (UPC), was defined as the number of dispensation days from the most frequented pharmacy divided by the total number of dispensation days. Adherence was defined as a Medication Possession Ratio of 80% or greater. Data were analyzed using hierarchical linear regression. Results The cohort of 25,641 subjects was 59% female with a mean age of 74 years. During follow-up, subjects filled prescriptions in a median of 2 (mean = 2; standard deviation = 0.88) pharmacies and visited pharmacies a median of 28 (mean = 30) times. During that time, 61% of patients used one pharmacy exclusively. Among subjects using 1 pharmacy, 59% were adherent while 58% using more than one pharmacy were adherent. However, upon adjustment for differences in distributions of age, sex, and other confounders, subjects who used more than one pharmacy had 10% decreased odds of statin adherence (odds ratio: 0.90, 95% confidence interval: 0.86–0.96). These results were robust in sensitivity analyses. Conclusions Among seniors newly starting statin therapy, using a single community pharmacy was modestly associated with adherence.
Original language | English |
---|---|
Pages (from-to) | e50-e60 |
Journal | Journal of Population Therapeutics and Clinical Pharmacology |
Volume | 24 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2017 |
Bibliographical note
Funding Information:This work was supported by a student Scotia Scholar award from the Nova Scotia Research Foundation and was made possible through data provided by CNODES and sharing agreements between CNODES and the province of Nova Scotia. No endorsement by the province of Nova Scotia is intended or should be inferred.
Funding Information:
CNODES is a collaborating centre of the Drug Safety and Effectiveness Network (DSEN) and is funded by the Canadian Institutes of Health Research (CIHR, Grant # DSE-111845). The data (or portions of the data) used in this report were made available by HDNS of Dalhousie University. Although this research is based on data obtained from the Nova Scotia Department of Health and Wellness, the observations and opinions expressed are those of the authors and do not represent those of either HDNS or the Department of Health and Wellness. Ingrid Sketris and Adrian Levy have received salary support from CNODES.
Publisher Copyright:
© 2017 Journal of Population Therapeutics and Clinical Pharmacology. All rights reserved.
ASJC Scopus Subject Areas
- Health Policy
- Pharmacology (medical)
PubMed: MeSH publication types
- Journal Article